Overcoming cancer relapse with CAR-Enhancer therapy
Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a ...
Tag: CAR T-cell
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear ...
Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO
At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center ...
Study finds no differences in CAR T-cell therapy outcomes among pediatric ALL patients across different socioeconomic levels
Social determinants of health affect the outcomes of many illnesses, and pediatric cancer is no exception. In fact, children with ...
CAR T-cell therapy produces impressive results in first clinical trial in patients with multiple myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced ...
Multiple Myeloma Treatment: What’s New?
Treatments for multiple myeloma have grown a great deal in the past few years. Newer drugs help people with this blood cancer live longer and enjoy ...
